HP and gastric cancer: Previously, we reported that 90.7% of diffuse-type early GC patients were Hp-IgG positive (vs. 75.9% of intestinal-type GC), and that the proportion of diffuse-type early GC increased significantly with increasing Hp-IgG titers [12].